> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FTC Moves to eFiling for Brand/Generic Drug Settlements
- URL: https://www.fdaweb.com/ftc-moves-to-efiling-for-brand-generic-drug-settlements/
- Published: 2019-06-07T12:00:00.000Z
- Updated: 2026-09-15T01:31:22.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5144289

The Federal Trade Commission (FTC) is implementing electronic filing to replace hard-copy submissions involving brand name and generic drug company agreements for antitrust reviews. Starting 6/17, such filings should be submitted to both the FTC at mma@ftc.gov and the Antitrust Division of the U.S. Department of Justice at mma@usdoj.gov. Companies will receive an emailed confirmation letter, along with a tracking number assigned by the agencies for use in any future correspondence about the filing, according to an [FTC notice](https://www.ftc.gov/news-events/press-releases/2019/06/pharmaceutical-agreement-filing-procedures-updated?ref=fdaweb.com). The notice also covers filing procedures for biological/biosimilar settlements.